Neurofibromatosis: clinical presentations and anaesthetic implications

Citation
Np. Hirsch et al., Neurofibromatosis: clinical presentations and anaesthetic implications, BR J ANAEST, 86(4), 2001, pp. 555-564
Citations number
114
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
BRITISH JOURNAL OF ANAESTHESIA
ISSN journal
00070912 → ACNP
Volume
86
Issue
4
Year of publication
2001
Pages
555 - 564
Database
ISI
SICI code
0007-0912(200104)86:4<555:NCPAAI>2.0.ZU;2-Z
Abstract
The neurofibromatoses are autosomal dominant diseases that have widespread effects on ectodermal and mesodermal tissue. The commonest member of the gr oup is neurofibromatosis type 1 (NF1) which varies in severity but which ca n affect all physiological systems. Neurofibromas are the characteristic le sions of the condition and not only occur in the neuraxis but may also be f ound in the oropharnyx and larynx; these may produce difficulties with lary ngoscopy and tracheal intubation. Pulmonary pathology includes pulmonary fi brosis and cystic lung disease. The cardiovascular manifestations of NF1 in clude hypertension, which may be associated with phaeochromocytoma or renal artery stenosis. Neurofibromas may also affect the gastrointestinal tract and carcinoid tumours may be found in the duodenum. This review documents t he aetiology and clinical manifestations of the neurofibromatoses and discu sses their relevance to the anaesthetist.